Tofacitinib, evt. i form av et farmasøytisk akseptabelt salt, inkludert citratsalt
- 专利权人:
- Pfizer Products Inc
- 发明人:
- 申请号：
- NO2017047
- 公开号：
- NO2017047I1
- 申请日:
- 2017.09.08
- 申请国别(地区):
- NO
- 年份:
- 2017
- 代理人:
- 摘要：
- The compound 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or a pharmaceutically acceptable salt thereof compositions containing the compound and uses of the compound in the manufacture of medicaments.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Tofacitinib, optionally in the form of a pharmaceutically acceptable salt, in particular tofacitinib citrate
- R R metil metil H pirolo d pirimidin yl amino piperidinil oksopropionitril kot inhibitor protein kinaze
- 3-((3R,4R)-4-METIL-3-[METIL-(7H-PIRROLO[2,3-D]PIRIMIDIN-4- IL)-AMINO]-PIPERIDINIL)-3-OXO-PROPIONITRILO COMO INIBIDOR DE CINASE PROTEICA
- 3 - ((3R, 4R) -4-methyl-3- [methyl- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino] -piperidinyl) -3-oxo-propionitrile as protein kinase inhibitor
- 3 - ((3R, 4R) -4-Methyl-3- [methyl- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -amino] -piperidinyl) -3-oxopropionitrile as a protein kinase inhibitor
